Delayed
OTC Markets
08:27:01 23/05/2024 pm IST
|
5-day change
|
1st Jan Change
|
0.0018
USD
|
0.00%
|
|
-5.26%
|
-45.45%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
28.21
|
27.28
|
6.94
|
40.02
|
11.21
|
5.482
|
Enterprise Value (EV)
1 |
27.73
|
26.37
|
-3.866
|
29.5
|
4.682
|
34.72
|
P/E ratio
|
-0.78
x
|
2.72
x
|
4.33
x
|
-22.9
x
|
-0.47
x
|
-0.12
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
3.36
x
|
0.32
x
|
0.05
x
|
0.57
x
|
0.33
x
|
0.34
x
|
EV / Revenue
|
3.3
x
|
0.31
x
|
-0.03
x
|
0.42
x
|
0.14
x
|
2.16
x
|
EV / EBITDA
|
-4.62
x
|
-25.9
x
|
-0.39
x
|
-13.4
x
|
-0.37
x
|
-2.46
x
|
EV / FCF
|
-
|
-9,81,420
x
|
-1,82,058
x
|
-
|
-2,11,515
x
|
-1,97,32,664
x
|
FCF Yield
|
-
|
-0%
|
-0%
|
-
|
-0%
|
-0%
|
Price to Book
|
-0.99
x
|
-21.1
x
|
2.34
x
|
6.5
x
|
0.49
x
|
-0.26
x
|
Nbr of stocks (in thousands)
|
64,860
|
1,11,365
|
1,36,072
|
1,60,081
|
2,88,924
|
3,22,452
|
Reference price
2 |
0.4350
|
0.2450
|
0.0510
|
0.2500
|
0.0388
|
0.0170
|
Announcement Date
|
30/07/18
|
10/07/19
|
08/07/20
|
10/06/21
|
21/06/22
|
23/06/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
8.392
|
85.92
|
131.4
|
70.7
|
34.42
|
16.1
|
EBITDA
1 |
-6.005
|
-1.017
|
9.824
|
-2.197
|
-12.68
|
-14.09
|
EBIT
1 |
-6.016
|
-1.1
|
9.695
|
-2.375
|
-13.33
|
-14.81
|
Operating Margin
|
-71.68%
|
-1.28%
|
7.38%
|
-3.36%
|
-38.73%
|
-92.01%
|
Earnings before Tax (EBT)
1 |
-35.79
|
21.42
|
3.274
|
-1.996
|
-20.14
|
-37.69
|
Net income
1 |
-35.79
|
21.42
|
2.789
|
-1.347
|
-17.11
|
-37.69
|
Net margin
|
-426.41%
|
24.93%
|
2.12%
|
-1.91%
|
-49.69%
|
-234.04%
|
EPS
2 |
-0.5600
|
0.0900
|
0.0118
|
-0.0109
|
-0.0830
|
-0.1400
|
Free Cash Flow
|
-
|
-26.87
|
21.24
|
-
|
-22.13
|
-1.759
|
FCF margin
|
-
|
-31.27%
|
16.16%
|
-
|
-64.3%
|
-10.93%
|
FCF Conversion (EBITDA)
|
-
|
-
|
216.17%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
761.57%
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
30/07/18
|
10/07/19
|
08/07/20
|
10/06/21
|
21/06/22
|
23/06/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
29.2
|
Net Cash position
1 |
0.48
|
0.92
|
10.8
|
10.5
|
6.53
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-2.075
x
|
Free Cash Flow
|
-
|
-26.9
|
21.2
|
-
|
-22.1
|
-1.76
|
ROE (net income / shareholders' equity)
|
-
|
-141%
|
287%
|
-
|
-118%
|
-71,537%
|
ROA (Net income/ Total Assets)
|
-
|
-6.28%
|
29.9%
|
-
|
-25.1%
|
-30.7%
|
Assets
1 |
-
|
-340.9
|
9.338
|
-
|
68.16
|
122.6
|
Book Value Per Share
2 |
-0.4400
|
-0.0100
|
0.0200
|
0.0400
|
0.0800
|
-0.0700
|
Cash Flow per Share
2 |
0.0100
|
0.0300
|
0.0800
|
0.0800
|
0.0600
|
0.0100
|
Capex
1 |
0.13
|
0.3
|
0.16
|
1
|
9.33
|
1.2
|
Capex / Sales
|
1.49%
|
0.34%
|
0.12%
|
1.41%
|
27.11%
|
7.43%
|
Announcement Date
|
30/07/18
|
10/07/19
|
08/07/20
|
10/06/21
|
21/06/22
|
23/06/23
|
|
1st Jan change
|
Capi.
|
---|
| -45.45% | 7L | | -.--% | 84Cr | | +6.30% | 72Cr | | +28.31% | 48Cr | | +31.88% | 26Cr | | 0.00% | 13Cr | | +139.13% | 6.55Cr |
Health Food Stores
|